tickrz reports
tickrz rank
D
Dentsply Sirona Inc (XRAY)
Healthcare | Health Services
58.26  0.78%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankN/AWarren Buffett RankD / 471
Pure Value RankN/ADividend RankD / 453
Moat RankD / 429Financial Strength RankC / 196
Growth RankA / 115Momentum RankD / 414
XRAY vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
XRAYSECTORS&P 500
P/E RATIO32.119.28
EV/EBITDA RATIO1711.77
P/S RATIO3.543.62.03
P/B RATIO1.875.53.09
QUALITY
RETURN ON EQUITY-10.14%15.64%13.82%
RETURN ON CAPITAL-8.45%50.61%10.04%
NET MARGIN11.48%8.18%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.56%
PAYOUT RATIO-9.38%
3 YR DIVIDEND GROWTH7.43%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
4 OUT OF 9
DEBT-TO-EQUITY22%
INTEREST COVERAGE15.11x
CURRENT RATIO2.34
GROWTH
5 YR EPS GROWTH2.68%
5 YR SPS GROWTH8.1%
5 YR BPS GROWTH22%
About tickrz
Key Concepts
Great Investors
Dentsply Sirona Inc 's strong growth translates to a Growth Rank in the top 25% of all stocks
tickrz rank N/A
Unfortunately we don't have enough data to calculate Dentsply Sirona Inc's tickrz rank.
value
pure value ranking N/AWarren Buffett ranking D / 471
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Dentsply Sirona Inc's valuation score is comprised of a P/B ratio of 1.9x, a P/S ratio of 3.5x, Dentsply Sirona Inc ranks NOT AVAILABLE out of the S&P 500 constituents on valuation--a relatively not available score.Dentsply Sirona Inc ranks 471 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Dentsply Sirona Inc is probably not for you.

quality
moat D / 429financial strength C / 196
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.Dentsply Sirona Inc has a Piotroski F Score of 4 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 15.11x, a debt/equity ratio of 22% and a Moat Rank of 429 translate to a weak Financial Strength score.


momentum D / 414
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -10.44% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 414. Based on its 12 month stock performance, Dentsply Sirona Inc will not appeal to momentum investors.

yield D / 453
value + yield
Shares currently yield 0.56%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Dentsply Sirona Inc ranks 453 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

growth A / 115
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 2.7% 5 year annualized EPS growth, 8.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 22% speak to its impressive growth ranking.

Dentsply Sirona Inc (XRAY)
Healthcare | Health Services
58.26  0.78%


tickrz rank
D
VALUATION RATIOS
P/E Ratiox
P/B Ratio1.87x
P/S Ratio3.54x
EV/EBITDA Ratiox
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.56%
PAYOUT RATIO-9.38%
3 YR DIVIDEND GROWTH7.43%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
4 OUT OF 9
DEBT-TO-EQUITY22%
INTEREST COVERAGE15.11x
CURRENT RATIO2.34
MOAT
ROE-10.14%
ROIC-8.45%
Net Margin11.48%
GROWTH
5 YR EPS GROWTH2.68%
5 YR SPS GROWTH8.1%
5 YR BPS GROWTH22%

TICKRZ RANK
Unfortunately we don't have enough data to calculate Dentsply Sirona Inc's tickrz rank.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Dentsply Sirona Inc's valuation score is comprised of a P/B ratio of 1.9x, a P/S ratio of 3.5x, Dentsply Sirona Inc ranks NOT AVAILABLE out of the S&P 500 constituents on valuation--a relatively not available score.

WARREN BUFFETT RANKING
Dentsply Sirona Inc ranks 471 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Dentsply Sirona Inc is probably not for you.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.

FINANCIAL STRENGTH
Dentsply Sirona Inc has a Piotroski F Score of 4 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 15.11x, a debt/equity ratio of 22% and a Moat Rank of 429 translate to a weak Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -10.44% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 414. Based on its 12 month stock performance, Dentsply Sirona Inc will not appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.56%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Dentsply Sirona Inc ranks 453 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 2.7% 5 year annualized EPS growth, 8.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 22% speak to its impressive growth ranking.